Cassava Sciences, Inc. (SAVA)

2.22 -0.10 (-4.31%) USD  |  NASDAQ  |  Jan 23, 10:06
More

Cassava Sciences Price Target Num Estimates

Price Target Num Estimates Chart

View Price Target Num Estimates for SAVA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price Target Num Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Price Target Num Estimates Range, Past 5 Years

View Price Target Num Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price Target Num Estimates Benchmarks

View Price Target Num Estimates Benchmarks
Start Trial
cbdMD, Inc. Upgrade
BioMarin Pharmaceutical, Inc. Upgrade
Amicus Therapeutics, Inc. Upgrade
Geron Corp. Upgrade
NovaBay Pharmaceuticals, Inc. Upgrade